Featured Research

from universities, journals, and other organizations

New Target Discovered To Treat Epileptic Seizures Following Brain Trauma Or Stroke

Date:
December 8, 2008
Source:
University of British Columbia
Summary:
New therapies for some forms of epilepsy may soon be possible, thanks to a new discovery by neuroscience researchers. The researchers found that hemichannels -- the same channels the researchers previously found to that cause cell death following a stroke -- may also cause epileptic seizures that occur following head trauma or a stroke.

New therapies for some forms of epilepsy may soon be possible, thanks to a discovery made by a team of University of British Columbia and Vancouver Coastal Health Research Institute neuroscience researchers.

The researchers found that hemichannels – the same channels the researchers previously found to that cause cell death following a stroke – may also cause epileptic seizures that occur following head trauma or a stroke.

The findings, published in Science, will allow researchers to focus on new treatments that block these channels. A hemichannelis a channel that can form in nerve cells which allows chemical ions to pass through.

“The glutamate receptor that is linked to cell death following a stroke also triggers opening of hemichannels,” says UBC Psychiatry Prof. Brian MacVicar, who is a member of the Brain Research Centre at UBC and VCH Research Institute. “Therefore both stroke itself or the glutamate released by a stroke can open hemichannels and cause cell death or epileptic seizures.”

The researchers tested the effect of glutamate at levels less than those reached during stroke and found that more moderate activation of glutamate receptors opens hemichannels and causes seizure but does not produce cell death associated with stroke.

Glutamate is one of the brain’s most abundant chemical messengers. Gap junctions are connections that allow molecules and ions, to flow between cells. Junctions are composed of two hemichannels that bridge intercellular space.

When epileptic seizures occur, hemichannels unexpectedly open near the synapses, which disrupt the normal electrical activity of the brain leading to seizures.

“We found that blocking hemichannels reduced the epilepsy-like discharges,” says Roger Thompson, a former UBC Psychiatry post-doctoral Fellow who is now an Assistant Professor of Cell Biology, Anatomy and Clinical Neurosciences at the University of Calgary.

“With these results we are confident that the discovery of safe blockers of hemichannels will provide a new therapy in the treatment to reduce cell loss and seizures that are caused by stroke,” says MacVicar, who also holds the Canada Research Chair in Neuroscience at UBC.

“The next step will be to develop a compound to block brain cell hemichannels from opening,” says MacVicar. “Therapies for epilepsy patients who have suffered a stroke or head trauma may be available within five to 10 years.”

According to the BC Epilepsy Society it is estimated that one out of 12 people will have a seizure in their lifetime, and close to one in 100 Canadians have epilepsy. An epileptic seizure is an abnormal burst of electrical activity within the brain.


Story Source:

The above story is based on materials provided by University of British Columbia. Note: Materials may be edited for content and length.


Cite This Page:

University of British Columbia. "New Target Discovered To Treat Epileptic Seizures Following Brain Trauma Or Stroke." ScienceDaily. ScienceDaily, 8 December 2008. <www.sciencedaily.com/releases/2008/12/081205094622.htm>.
University of British Columbia. (2008, December 8). New Target Discovered To Treat Epileptic Seizures Following Brain Trauma Or Stroke. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2008/12/081205094622.htm
University of British Columbia. "New Target Discovered To Treat Epileptic Seizures Following Brain Trauma Or Stroke." ScienceDaily. www.sciencedaily.com/releases/2008/12/081205094622.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins